• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Human trial of world's first coronavirus vaccine completed, claims Russian embassy

|

Moscow, July 13: As the world races towards finding an effective and safe vaccine against the novel coronavirus, Russia's Sechenov First Moscow State Medical University has completed the human trials of the world's first Covid-19 vaccine on their volunteers.

    Coronavirus: Russian University claims successful trials of 1st Covid vaccine | Oneindia News

    Human trial of worlds first coronavirus vaccine completed, claims Russian embassy

    "Sechenov University has successfully completed tests on volunteers of the world's first vaccine against #COVID19. The #vaccine is safe. The volunteers will be discharged on July 15 and July 20," chief researcher Elena Smolyarchuk told TASS," the embassy tweeted.

    According to Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, told Sputnik that the first batch of volunteers will be discharged on Wednesday, whereas, the second will be discharged on July 20.

    COVAXIN: Human trial of India's first Covid-19 vaccine begins at NIMS Hyderabad

    Tarasov said,"Sechenov University has successfully completed tests on volunteers of the world's first vaccine against coronavirus.''

    The university began the trials on June 18 and the vaccines were produced by Russia's Gamalei Institute of Epidemiology and Microbiology.

    Before this, China's Sinovac Biotech became the latest company to start Phase III trials of its coronavirus vaccine candidate, following a fast-track approval by regulators last week. Sinovac has started Phase III trials in Brazil.

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    X
    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more